The OncFive: Top Oncology Articles for the Week of 5/11

Top 5 Articles of the Week: May 11-16

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

The Targeted Pulse: FDA Approvals in Ovarian Cancer, Lung Cancer, and More

The FDA has approved new agents in ovarian cancer and non–small cell lung cancer and paved the way for novel antibody-drug conjugate developments.

Incyte’s Zynyz receives FDA approval for anal cancer treatment

WILMINGTON — Incyte, one of Delaware’s top pharmaceutical companies, has secured U.S. Food and Drug Administration (FDA) approval to use Zynyz as a treatment for anal cancer. Zynyz, an intravenous PD-1 inhibitor, may now be used in combination with platinum-based chemotherapy as well as a monotherapy for metastatic squamous cell carcinoma (SCAC), which makes up [...]

The OncFive: Top Oncology Articles for the Week of 5/11

The FDA has approved options in non–small cell lung cancer, advanced anal cancer, and pheochromocytoma or paraganglioma, and more from OncLive this week.